Stryker (SYK) Cash from Operations Growth (3y) (2012 - 2026)
Powered by 
Analysis
Stryker (SYK) Cash from Operations Growth (3y) (2012 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.54 Bn | 177.93 Bn | 7.27 Bn | 27.41% |
| 2 | Intuitive Surgical | 124.70 Bn | 119.48 Bn | 1.96 Bn | 16.81% |
| 3 | Medtronic | 117.91 Bn | 109.09 Bn | 6.34 Bn | 27.02% |
| 4 | Stryker | 105.72 Bn | 102.25 Bn | 4.50 Bn | 22.38% |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 30.85% |
| 6 | Edwards Lifesciences | 49.52 Bn | 45.27 Bn | 1.35 Bn | 168.71% |
| 7 | Alcon | 33.89 Bn | 32.43 Bn | 1.68 Bn | 16.21% |
| 8 | Dexcom | 32.10 Bn | 30.15 Bn | 830.00 Mn | 12.26% |
| 9 | Steris | 21.06 Bn | 20.58 Bn | 684.20 Mn | 9.30% |
| 10 | Zimmer Biomet Holdings | 18.26 Bn | 17.85 Bn | 1.54 Bn | 8.78% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 22.38% |
| Mar 31, 2026 | 9.30% |
| Dec 31, 2025 | 28.80% |
| Sep 30, 2025 | 20.10% |
| Jun 30, 2025 | 28.06% |
| Mar 31, 2025 | 7.19% |
| Dec 31, 2024 | 24.53% |
| Sep 30, 2024 | 16.47% |
| Jun 30, 2024 | -10.33% |
| Mar 31, 2024 | -23.29% |
| Dec 31, 2023 | 7.30% |
| Sep 30, 2023 | 8.20% |
| Jun 30, 2023 | 3.53% |
| Mar 31, 2023 | -9.02% |
| Dec 31, 2022 | 10.92% |
| Sep 30, 2022 | 12.22% |
| Jun 30, 2022 | 0.96% |
| Mar 31, 2022 | -13.44% |
| Dec 31, 2021 | -1.49% |
| Sep 30, 2021 | 14.72% |